Results 251 to 260 of about 9,113,589 (351)
Antitumor Necrosis Factor-Refractory Esophageal Lesions in Crohn's Disease Successfully Treated With Upadacitinib. [PDF]
Nakamura N+7 more
europepmc +1 more source
Micro‐ and nanomotors in biomedical applications
Micro‐ and nanomotors (MNMs), as autonomous devices converting chemical or external energy into mechanical propulsion, have emerged as transformative drug delivery platforms in biomedicine. This review systematically outlines the design principles governing MNMs' propulsion and operation, highlights the applications of MNMs in disease treatment, and ...
Xiangyu Meng, Yuqi Tang, Quan Li
wiley +1 more source
Surgery time for stenosed Crohn's disease: Case report. [PDF]
Nofal MN+3 more
europepmc +1 more source
There was a positive correlation between apnea/hypopnea index (AHI) index and platelet aggregation and a negative correlation between CD42b and multidrug resistance protein 1 (MRP1). Platelet activation was high while MRP1 expression was low in severe obstructive sleep apnea syndrome (OSAS) independent of smoking, age, and gender.
Cigdem Bayram Gurel+8 more
wiley +1 more source
Iliopsoas Abscess Heralding the Diagnosis of Crohn's Disease in a Young Male. [PDF]
Ali M+4 more
europepmc +1 more source
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease.
F. Ruemmele+32 more
semanticscholar +1 more source
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai+5 more
wiley +1 more source
Stool Biomarkers as a Clue for Developing Crohn's Disease in Idiopathic Pyoderma Gangrenosum Patients. [PDF]
Dawood M, Khamaysi Z, Avitan-Hersh E.
europepmc +1 more source
Nanomedicine for Oral Delivery: Strategies to Overcome the Biological Barriers
Oral delivery is a preferred administration route for many clinical applications, valued for its strong patient compliance. In this review, how nanoparticles are engineered and deployed to overcome the gastrointestinal barriers that impede clinical translation of oral delivery formulations is examined.
Luke J. Kubiatowicz+5 more
wiley +1 more source
A case of Crohn's disease in a patient with megacystis microcolon intestinal hypoperistalsis syndrome. [PDF]
Putzeys CC+8 more
europepmc +1 more source